Lessons From Aduhelm: Don’t Go Over Your FDA Review Team’s Head, Pazdur Says

US FDA’s oncology chief says he won’t talk to sponsors unilaterally when a company takes issue with their review division. Pazdur also weighed in on his long-term career plans and his views on the FDA-industry revolving door at two ASCO interviews. 

Richard Pazdur
FDA's Rick Pazdur spoke about accelerated approval, his future and FDA hiring at ASCO

More from Agency Leadership

More from Pink Sheet